SCHEMBL4470001

SCHEMBL4470001

c1cc(N2CCCC2)ccc1[C@H]1CCOC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.43
KCNH2 Q12809 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
L3MBTL3 Q96JM7 2/20 0.42
PDE9A O76083 1/20 0.40
ALDH1A1 P00352 6/20 0.39
MAPT P10636 4/20 0.39
NPSR1 Q6W5P4 2/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 2/20 0.39
NPC1 O15118 2/20 0.39
HTT P42858 2/20 0.39
RAB9A P51151 2/20 0.39
KMT2A Q03164 2/20 0.39
USP2 O75604 1/20 0.39
TP53 P04637 1/20 0.39
POLB P06746 1/20 0.39
GAA P10253 1/20 0.39
THRB P10828 1/20 0.39
ALOX15 P16050 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4480849 1.00 HRH3 (0.43) HRH3KCNH2L3MBTL1L3MBTL3PDE9A
SCHEMBL4461599 0.91 HRH3 (0.50) HRH3KCNH2L3MBTL1L3MBTL3PDE9A
SCHEMBL30700722 0.87 HRH3 (0.47) HRH3KCNH2L3MBTL1L3MBTL3PDE9A
Hydrochloric Acid SCHEMBL31308866 0.86 HRH3 (0.46) HRH3KCNH2L3MBTL1L3MBTL3PDE9A
SCHEMBL5165447 0.82 ALDH1A1 (0.50) HRH3KCNH2ALDH1A1MAPTKDM4E
SCHEMBL23064493 0.79 L3MBTL1 (0.52) HRH3L3MBTL1L3MBTL3ALDH1A1MAPT
SCHEMBL30228474 0.77 ALDH1A1 (0.52) L3MBTL1L3MBTL3ALDH1A1MAPTNPSR1
SCHEMBL28247589 0.76 ALDH1A1 (0.52) HRH3KCNH2L3MBTL1L3MBTL3ALDH1A1
SCHEMBL2175616 0.72 LMNA (0.62) L3MBTL1ALDH1A1MAPTNPSR1KDM4E
SCHEMBL615270 0.72 L3MBTL1 (0.43) HRH3KCNH2L3MBTL1L3MBTL3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8853243-B2 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases INCYTE CORPORATION (US) 2014-10-07 US disclosed
US-7491724-B2 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases INCYTE CORPORATION (US) 2009-02-17 US disclosed
US-20050113344-A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases INCYTE CORPORATION 2005-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113344-A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases MMP25, MMP2, MMP14 HRH3 299/4885KCNH2 4625/4885L3MBTL1 3117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.